AIM IMMUNOTECH INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
AIM IMMUNOTECH INC. (AIM) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $1.49 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2018-11-14
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-12-31 was -$24.00K.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-09-30 was $84.00K.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2017-06-30 was $1.27M.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2017 was $2.05M, a 21.67% decline from fiscal 2016.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2016 was $2.62M.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2014 was -$14.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.49M 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $1.49M 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $60.00K derived: sum of 2 quarters · filed 2018-03-30 | $1.33M derived: sum of 3 quarters · filed 2018-03-30 | $2.05M 10-K · filed 2018-03-30 |
| 2017-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.35M derived: sum of 2 quarters · filed 2017-11-14 | $2.07M 10-Q · filed 2017-11-14 | $2.07M derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.99M 10-Q · filed 2017-08-14 | $1.99M derived: sum of 3 quarters · filed 2017-08-14 | |
| 2017-03-31 | $723.00K 10-Q · filed 2017-05-15 | $723.00K derived: sum of 2 quarters · filed 2017-05-15 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.62M 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $2.62M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | -$14.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |